U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C18H23N5O21P4.4Na
Molecular Weight 861.2502
Optical Activity UNSPECIFIED
Defined Stereocenters 7 / 7
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DENUFOSOL TETRASODIUM

SMILES

[Na+].[Na+].[Na+].[Na+].NC1=NC(=O)N(C=C1)[C@H]2C[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OP([O-])(=O)OP([O-])(=O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)N4C=CC(=O)NC4=O)O2

InChI

InChIKey=PASYJVRFGUDDEW-WMUGRWSXSA-J
InChI=1S/C18H27N5O21P4.4Na/c19-11-1-3-22(17(28)20-11)13-5-8(24)9(40-13)6-38-45(30,31)42-47(34,35)44-48(36,37)43-46(32,33)39-7-10-14(26)15(27)16(41-10)23-4-2-12(25)21-18(23)29;;;;/h1-4,8-10,13-16,24,26-27H,5-7H2,(H,30,31)(H,32,33)(H,34,35)(H,36,37)(H2,19,20,28)(H,21,25,29);;;;/q;4*+1/p-4/t8-,9+,10+,13+,14+,15+,16+;;;;/m0..../s1

HIDE SMILES / InChI
Denufosol is a novel second-generation, metabolically stable, selective P2Y(2) receptor agonist. As ion channel regulator denufosol corrects the ion transport defect and increases the overall mucociliary clearance in cystic fibrosis (CF) lung disease by increasing chloride secretion, inhibiting sodium absorption, and increasing ciliary beat frequency in the airway epithelium independently of cystic fibrosis transmembrane conductance regulator genotype. Denufosol improved lung function relative to placebo in cystic fibrosis patients with normal to mildly impaired lung function. The drug half-life is 25 hours in ex vivo CF sputum and 3 hours when added in vitro to human respiratory epithelial cultures. Denufosol has been generally well-tolerated in healthy volunteers and patients with cystic fibrosis. The most common adverse events were in the respiratory system, with cough having the highest frequency.

Approval Year

PubMed

PubMed

TitleDatePubMed
Pharmacology of INS37217 [P(1)-(uridine 5')-P(4)- (2'-deoxycytidine 5')tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis.
2002 Sep

Sample Use Guides

60 mg three times daily
Route of Administration: Respiratory
Name Type Language
DENUFOSOL TETRASODIUM
MART.   USAN  
USAN  
Official Name English
URIDINE 5'-(PENTAHYDROGEN TETRAPHOSPHATE), P'''->5'-ESTER WITH ''-DEOXYCYTIDINE, TETRASODIUM SALT
Common Name English
2'-DEOXYCYTIDINE(5')TETRAPHOSPHO(5')URIDINE TETRASODIUM SALT
Common Name English
DENUFOSOL TETRASODIUM SALT
MI  
Common Name English
DENUFOSOL TETRASODIUM [USAN]
Common Name English
INS-37217
Code English
DENUFOSOL TETRASODIUM SALT [MI]
Common Name English
INS37217
Code English
DENUFOSOL TETRASODIUM [MART.]
Common Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/05/342
Created by admin on Fri Dec 15 16:25:13 GMT 2023 , Edited by admin on Fri Dec 15 16:25:13 GMT 2023
FDA ORPHAN DRUG 139400
Created by admin on Fri Dec 15 16:25:13 GMT 2023 , Edited by admin on Fri Dec 15 16:25:13 GMT 2023
Code System Code Type Description
DRUG BANK
DBSALT000847
Created by admin on Fri Dec 15 16:25:13 GMT 2023 , Edited by admin on Fri Dec 15 16:25:13 GMT 2023
PRIMARY
PUBCHEM
10219163
Created by admin on Fri Dec 15 16:25:13 GMT 2023 , Edited by admin on Fri Dec 15 16:25:13 GMT 2023
PRIMARY
USAN
PP-73
Created by admin on Fri Dec 15 16:25:13 GMT 2023 , Edited by admin on Fri Dec 15 16:25:13 GMT 2023
PRIMARY
CAS
318250-11-2
Created by admin on Fri Dec 15 16:25:13 GMT 2023 , Edited by admin on Fri Dec 15 16:25:13 GMT 2023
PRIMARY
MERCK INDEX
m4168
Created by admin on Fri Dec 15 16:25:13 GMT 2023 , Edited by admin on Fri Dec 15 16:25:13 GMT 2023
PRIMARY Merck Index
ChEMBL
CHEMBL507282
Created by admin on Fri Dec 15 16:25:13 GMT 2023 , Edited by admin on Fri Dec 15 16:25:13 GMT 2023
PRIMARY
NCI_THESAURUS
C171672
Created by admin on Fri Dec 15 16:25:13 GMT 2023 , Edited by admin on Fri Dec 15 16:25:13 GMT 2023
PRIMARY
SMS_ID
100000177150
Created by admin on Fri Dec 15 16:25:13 GMT 2023 , Edited by admin on Fri Dec 15 16:25:13 GMT 2023
PRIMARY
FDA UNII
82M942WZ4A
Created by admin on Fri Dec 15 16:25:13 GMT 2023 , Edited by admin on Fri Dec 15 16:25:13 GMT 2023
PRIMARY